Shandong Buchang Pharmaceuticals (603858.SH): Atomoxetine Hydrochloride Oral Solution Obtained Drug Registration Certificate

Zhitong Finance APP News, Buchang Pharmaceutical (603858.SH) announced that the company recently received the "Drug Registration Certificate" for Atomoxetine Hydrochloride Oral Solution approved and issued by the National Medical Products Administration. The drug is used to treat attention-deficit/hyperactivity disorder (ADHD) in children and adolescents aged 6 years and older.